Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 10 of 77 descriptions
| No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Abatacept, rituximab or tocilizumab | [3] Abatacept Abatacept,Rituximab, Tocilizumab | [3] Tocilizumab
Tocilizumab
,Rituximab , Abatacept 💬 1. Abatacept, rituximab or tocilizumab
| [4] CD80 CD80,CD86, IL6R, MS4A1 💬 | [25] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Adenovirus 💬 [25] Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - ... | [1] 46 46 💬1. Abatacept, rituximab or tocilizumab
| ||||||||||||||
| 2 | ABP 798 - Biosimilar to rituximab | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬2. ABP 798 - Biosimilar to rituximab
| [1] MS4A1 MS4A1 💬2. ABP 798 - Biosimilar to rituximab
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 💬2. ABP 798 - Biosimilar to rituximab
| ||||||||||||||
| 3 | ABP 798 Biosimilar to Rituximab | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬3. ABP 798 Biosimilar to Rituximab
| [1] MS4A1 MS4A1 💬3. ABP 798 Biosimilar to Rituximab
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 💬3. ABP 798 Biosimilar to Rituximab
| ||||||||||||||
| 4 | Administration of rituximab and methylprednisolone | [2] Methylprednisolone Methylprednisolone,Rituximab | [2] Methylprednisolone
Methylprednisolone
,Rituximab 💬 4. Administration of rituximab and methylprednisolone
| [2] MS4A1 MS4A1,NR3C1 💬 | [2] Hematopoietic cell lineage Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬 | [1] 51 51 💬4. Administration of rituximab and methylprednisolone
| ||||||||||||||
| 5 | Alemtuzumab and Rituximab | [2] Alemtuzumab Alemtuzumab,Rituximab | [2] Alemtuzumab
Alemtuzumab
,Rituximab 💬 5. Alemtuzumab and Rituximab
| [2] CD52 CD52,MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 60 60 💬5. Alemtuzumab and Rituximab
| ||||||||||||||
| 6 | Alemtuzumab, Rituximab | [2] Alemtuzumab Alemtuzumab,Rituximab | [2] Alemtuzumab
Alemtuzumab
,Rituximab 💬 6. Alemtuzumab, Rituximab
| [2] CD52 CD52,MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 63 63 💬6. Alemtuzumab, Rituximab
| ||||||||||||||
| 7 | Belimumab in SLE patients / Rituximab in RA patients | [2] Belimumab Belimumab,Rituximab | [2] Rituximab
Rituximab
,Belimumab 💬 7. Belimumab in SLE patients / Rituximab in RA patients
| [2] MS4A1 MS4A1,TNFSF13B 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Intestinal immune network fo ... | [2] 46 46, 49 💬
| ||||||||||||||
| 8 | Bendamustine, Rituximab | [2] Bendamustine Bendamustine,Rituximab | [2] Rituximab
Rituximab
,Bendamustine 💬 8. Bendamustine, Rituximab
| [1] MS4A1 MS4A1 💬8. Bendamustine, Rituximab
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 61 61 💬8. Bendamustine, Rituximab
| ||||||||||||||
| 9 | Combination of Protein A Immunoadsorption, Rituximab, Dexamethasone plus Azathioprine | [3] Azathioprine Azathioprine,Dexamethasone, Rituximab | [3] Azathioprine
Azathioprine
,Dexamethasone , Rituximab 💬 9. Combination of Protein A Immunoadsorption, Rituximab, Dexamethasone plus Azathioprine
| [2] MS4A1 MS4A1,NR3C1 💬 | [2] Hematopoietic cell lineage Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬 | [1] 35 35 💬9. Combination of Protein A Immunoadsorption, Rituximab, Dexamethasone plus Azathioprine
| ||||||||||||||
| 10 | Combination of Rituximab | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬10. Combination of Rituximab
| [1] MS4A1 MS4A1 💬10. Combination of Rituximab
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 63 63 💬10. Combination of Rituximab
|